In an era of widespread genetic sequencing, the ability to edit and alter an organism’s DNA is a powerful way to explore the information within and how it guides biological function.
A paper from the University of Wisconsin-Madison in the August issue of the journal GENETICS takes genome editing to a new level in fruit flies, demonstrating a remarkable level of fine control and, importantly, the transmission of those engineered genetic changes across generations.
Both features are key for driving the utility and spread of an approach that promises to give researchers new insights into the basic workings of biological systems, including embryonic development, nervous system function, and the understanding of human disease.
“Genome engineering allows you to change gene function in a very targeted way, so you can probe function at a level of detail” that wasn’t previously possible, says Melissa Harrison, an assistant professor of biomolecular chemistry in the UW-Madison School of Medicine and Public Health and one of the three senior authors of the new study.
Disrupting individual genes has long been used as a way to study their roles in biological function and disease. The new approach, based on molecules that drive a type of bacterial immune response, provides a technical advance that allows scientists to readily engineer genetic sequences in very detailed ways, including adding or removing short bits of DNA in chosen locations, introducing specific mutations, adding trackable tags, or changing the sequences that regulate when or where a gene is active.
The approach used in the new study, called the CRISPR RNA/Cas9 system, has developed unusually fast. First reported just one year ago by scientists at the Howard Hughes Medical Institute and University of California, Berkeley, it has already been applied to most traditional biological model systems, including yeast, zebrafish, mice, the nematode C. elegans, and human cells. The Wisconsin paper was the first to describe it in fruit flies and to show that the resulting genetic changes could be passed from one generation to the next.
“There was a need in the community to have a technique that you could use to generate targeted mutations,” says Jill Wildonger, a UW-Madison assistant professor of biochemistry and another senior author of the paper. “The need was there and this was the technical advance that everyone had been waiting for.”
“The reason this has progressed so quickly is that many researchers — us included — were working on other, more complicated, approaches to do exactly the same thing when this came out,” adds genetics assistant professor Kate O’Connor-Giles, the third senior author. “This is invaluable for anyone wanting to study gene function in any organism and it is also likely to be transferable to the clinical realm and gene therapy.”
The CRISPR RNA/Cas9 system directs a DNA-clipping enzyme called Cas9 to snip the DNA at a targeted sequence. This cut then stimulates the cell’s existing DNA repair machinery to fill in the break while integrating the desired genetic tweaks. The process can be tailored to edit down to the level of a single base pair — the rough equivalent of changing a single letter in a document with a word processor.
The broad applicability of the system is aided by a relatively simple design that can be customized through creation of a short RNA sequence to target a specific sequence in the genome to generate the desired changes. Previous genome editing methods have relied on making custom proteins, which is costly and slow.
“This is so readily transferable that it’s highly likely to enable gene knockout and other genome modifications in any organism,” including those that have not previously been used for laboratory work, says O’Connor-Giles. “It’s going to turn non-model organisms into genetic model organisms.”
That ease may also pay off in the clinic. “It can be very difficult and time-consuming to generate models to study all the gene variants associated with human diseases,” says Wildonger. “With this genome editing approach, if we work in collaboration with a clinician to find [clinically relevant] mutations, we can rapidly translate these into a fruit fly model to see what’s happening at the cellular and molecular level.”
The Latest Bing News on:
- Genome editing technology to ensure food securityon December 6, 2022 at 8:14 am
The utilisation of Genome Editing (GEd), a scientific technology, can help develop pests-resistance seed varieties to boost food security, Dr Olalekan Akinbo, Supervisor AUDA-NEPAD Centre of ...
- 2 Risky Stocks That Could Soar in 2023on December 6, 2022 at 7:07 am
Investing in small-cap stocks can be very risky. These companies aren't worth much for a reason; most investors don't see them as attractive options. And while the majority isn't always right, it is ...
- AUDA-NEPAD supports Ethiopia’s genome editing communication strategyon December 6, 2022 at 3:36 am
The national strategy development effort which is also meant to institutional level experience sharing has brought about biotechnology and media experts together to design the national communication ...
- Precision BioSciences: A Watch List Stock Going Into ASH Presentationon December 6, 2022 at 12:34 am
Precision BioSciences is slated to present a poster at the 64th ASH Annual Meeting between December 10th and 13th. See why DTIL stock is a Buy.
- Ethiopia Developing Genome Editing Communication Strategyon December 5, 2022 at 4:00 pm
By Mekonnen Teshome The Centre of Excellence in Science, Technology, and Innovation of the African Union Development Agency-NEPAD (AUDA-NEPAD) is supporting Ethiopian Bio and Emerging Technology ...
- How to edit the genes of nature's master manipulatorson December 5, 2022 at 2:37 pm
CRISPR, the Nobel Prize-winning gene editing technology, is poised to have a profound impact on the fields of microbiology and medicine yet again. A team has developed a tool to edit the genomes of ...
- Genome Engineering Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027on December 5, 2022 at 4:50 am
Reportlinker.com announces the release of the report "Genome Engineering Market - Global Industry Size, Share, Trends ...
- Genome Editing Market : Industry Analysis 2022 To 2028 based on Sales, Revenue, Size and Shareon December 1, 2022 at 7:13 pm
By Types (CRISPR, TALEN, ZFN), By Segmentation analysis, Regions and Forecast to 2028. The Global Genome Editing market Report provides In-depth analysis on the market status of the Genome Editing Top ...
- Third International Summit on Human Genome Editing to Take Place in London March 6-8, 2023on November 30, 2022 at 3:03 pm
Building on previous events held in Washington, DC (2015) and Hong Kong (2018), the London meeting will continue the global dialogue on the scientific, ethical, and governance issues surrounding ...
- Mining (and Refining) the Stuff of Gene Editing Toolson November 7, 2022 at 3:15 pm
Although CRISPR-Cas9 offers advantages over earlier genome editing methods, it isn’t necessarily the last word. Indeed, the past decade has revealed limitations of CRISPR-Cas9, which can’t ...
The Latest Google Headlines on:
[google_news title=”” keyword=”Genome editing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
- How to edit the genes of nature's master manipulatorson December 5, 2022 at 7:32 am
CRISPR, the Nobel Prize-winning gene editing technology, is poised to have a profound impact on the fields of microbiology and medicine yet again.
- How the CRISPR Gene Editor Can Activate Protein Scissorson December 1, 2022 at 12:52 pm
The CRISPR/Cas9 gene editing tool has changed biomedical research, and has even been used in the clinic in a few cases to treat, or attempt to treat, disease. CRISPR comes from a kind of bacterial ...
- New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bioon November 30, 2022 at 4:08 pm
This is a non-exclusive license agreement granting Japan's Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene ...
- The Promise of RNA-Based Therapieson November 30, 2022 at 9:15 am
when used with gene editing enzymes (e.g., in CRISPR-Cas9), can direct the editing of DNA or RNA RNA therapies tend to be quicker to develop, approve, and see widespread adoption than existing ...
- Virus-derived CRISPR systems may be added to the gene-editing toolboxon November 30, 2022 at 3:55 am
Researchers have highlighted the potential use of virus-derived CRISPR machinery in new gene-editing approaches.
- Thousands of phages found to have CRISPR gene editing systemon November 28, 2022 at 4:00 pm
In 2012, some of the researchers on this same team discovered that CRISPR-Cas9 could be programmed using RNA to edit targeted DNA strands from other organisms (and won a Nobel prize for it).
- CRISPR Technology Global Market Report 2022: Use of CRISPR in Diagnostics to Bolster 23.7% Annual Growthon November 26, 2022 at 7:16 am
The main types of products in CRISPR technology are design tools, plasmid and vector, CAS9 and G-RNA and delivery system products. CRISPR-Cas9 is a groundbreaking technology that allows ...
- CRISPR Technology Global Market Report 2022: Use of CRISPR in Diagnostics to Bolster 23.7% Annual Growthon November 25, 2022 at 9:16 am
The "CRISPR Technology Global Market Report 2022, By Product Type, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering.
- New CRISPR gene-editing system can "drag-and-drop" DNA in bulkon November 23, 2022 at 4:00 pm
Rather than the “cut-and-paste” method of existing CRISPR-Cas9, the team describes the new ... to cut DNA in a location specified by guide RNA, but the difference is that the new system ...
- CRISPR Technology To Simplify And Enhance CAR T Cancer Treatmenton November 23, 2022 at 4:31 am
Researchers find that combining novel gene-editing CRISPR technology with CAR T therapy could simplify and improve CAR T therapy in one fell swoop.
The Latest Google Headlines on:
[google_news title=”” keyword=”CRISPR RNA/Cas9″ num_posts=”10″ blurb_length=”0″ show_thumb=”left”]